High Cutoff Versus High-Flux Haemodialysis for Myeloma Cast Nephropathy in Patients Receiving Bortezomib-Based Chemotherapy (EuLITE): A Phase 2 Randomised Controlled Trial
The Lancet Haematology - United Kingdom
doi 10.1016/s2352-3026(19)30014-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2019
Authors
Publisher
Elsevier BV